Founded in 2014, Pathnostics specializes in diagnostic tests and services across a range of therapeutic areas, including urology, women's health, gastroenterology and cancer. The company has grown rapidly in recent years as increasing numbers of urologists have adopted its Guidance UTI test, which simultaneously diagnoses and guides antibiotic treatment for complex, recurring urinary tract infections. This test utilizes proprietary technology featuring combined phenotypic sensitivity and genotypic resistance to conquer unresolved infections and rapidly provide therapeutic guidance to physicians.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/01/19 | undisclosed |
Water Street Healthcare Partners | undisclosed |
